看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 5.8x - 6.5x | 6.2x |
| Selected Fwd EBITDA Multiple | 5.5x - 6.0x | 5.7x |
| Fair Value | €23.23 - €27.63 | €25.43 |
| Upside | 30.5% - 55.1% | 42.8% |
| Benchmarks | Ticker | Full Ticker |
| Core Laboratories Inc. | CLB | NYSE:CLB |
| Patterson-UTI Energy, Inc. | PTEN | NasdaqGS:PTEN |
| RPC, Inc. | RES | NYSE:RES |
| Liberty Energy Inc. | LBRT | NYSE:LBRT |
| NOV Inc. | NOV | NYSE:NOV |
| Helmerich & Payne, Inc. | HPC | DB:HPC |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| CLB | PTEN | RES | LBRT | NOV | HPC | ||
| NYSE:CLB | NasdaqGS:PTEN | NYSE:RES | NYSE:LBRT | NYSE:NOV | DB:HPC | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | -11.7% | 17.1% | 10.5% | 26.8% | 78.5% | 1.7% | |
| 3Y CAGR | 3.9% | 87.5% | 41.6% | 109.0% | 99.1% | 132.0% | |
| Latest Twelve Months | -11.4% | -26.6% | -18.6% | -32.1% | -2.5% | 3.9% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 13.3% | 21.9% | 13.9% | 14.6% | 7.8% | 21.2% | |
| Prior Fiscal Year | 14.2% | 28.4% | 22.4% | 24.8% | 12.0% | 31.9% | |
| Latest Fiscal Year | 12.8% | 22.3% | 15.7% | 20.6% | 15.3% | 30.3% | |
| Latest Twelve Months | 12.1% | 20.2% | 14.4% | 17.5% | 13.5% | 24.8% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.37x | 0.64x | 0.65x | 0.51x | 0.68x | 1.22x | |
| EV / LTM EBITDA | 11.3x | 3.2x | 4.5x | 2.9x | 5.1x | 4.9x | |
| EV / LTM EBIT | 14.7x | 895.3x | 16.2x | 10.4x | 7.4x | 12.3x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 2.9x | 4.5x | 11.3x | ||||
| Historical EV / LTM EBITDA | 2.9x | 4.7x | 164.4x | ||||
| Selected EV / LTM EBITDA | 5.8x | 6.2x | 6.5x | ||||
| (x) LTM EBITDA | 850 | 850 | 850 | ||||
| (=) Implied Enterprise Value | 4,972 | 5,233 | 5,495 | ||||
| (-) Non-shareholder Claims * | (2,148) | (2,148) | (2,148) | ||||
| (=) Equity Value | 2,824 | 3,086 | 3,347 | ||||
| (/) Shares Outstanding | 99.4 | 99.4 | 99.4 | ||||
| Implied Value Range | 28.40 | 31.03 | 33.66 | ||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | |||
| Implied Value Range (Trading Cur) | 24.38 | 26.63 | 28.89 | 17.81 | |||
| Upside / (Downside) | 36.9% | 49.5% | 62.2% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | CLB | PTEN | RES | LBRT | NOV | HPC | |
| Enterprise Value | 706 | 3,236 | 921 | 2,084 | 5,987 | 4,211 | |
| (+) Cash & Short Term Investments | 31 | 184 | 162 | 20 | 1,080 | 187 | |
| (+) Investments & Other | 0 | 0 | 0 | 86 | 178 | 102 | |
| (-) Debt | (179) | (1,287) | (81) | (517) | (2,371) | (2,335) | |
| (-) Other Liabilities | (6) | (6) | 0 | 0 | (54) | (103) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 553 | 2,126 | 1,002 | 1,673 | 4,820 | 2,063 | |
| (/) Shares Outstanding | 46.9 | 385.2 | 216.9 | 162.0 | 371.4 | 99.4 | |
| Implied Stock Price | 11.79 | 5.52 | 4.62 | 10.33 | 12.98 | 20.75 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |
| Implied Stock Price (Trading Cur) | 11.79 | 5.52 | 4.62 | 10.33 | 12.98 | 17.81 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.17 | |